1st patient enrolled in Penthrox paediatrics trial in Europe
Filed with ASX · · 2 pages · English
Watch Medical Developments International's latest callMedical Developments International (ASX:MVP) Q4 2026 Earnings Call · Replay · Aug 19Read the transcript of Medical Developments International (ASX:MVP) Q4 2026 Earnings CallMedical Developments International Limited on 6ix
In the deck
Earlier from Medical Developments International
- MVP signs Respiratory Device supply deal with Sams Club
- Penthrox Regulatory Dossier accepted for review in Canada
- MVP signs significant Development Project with CSIRO
- Penthrox replaces Nitrous Oxide in New Zealand Ambulance
- MVP Respiratory devices now available in USA Costcos
Later from Medical Developments International
- Penthrox recommended for use in all UK ambulances
- Chairman sells 4.35 million shares
- Penthrox approved in Mexico
- Penthrox approved in another 22 European countries
- Penthrox approved in Iceland
Follow Medical Developments International into a list and get an email when it puts out news.
Follow Medical Developments International